Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-10 1:26 pm Purchase | 2022-01-07 | 13G | Janux Therapeutics, Inc. JANX | FMR LLC | 4,991,402 11.995% | 4,991,402 (New Position) | Filing History |
| 2021-12-17 5:08 pm Purchase | 2021-12-16 | 13D | Janux Therapeutics, Inc. JANX | ORBIMED ADVISORS LLC | 2,649,464 6.400% | 2,649,464 (New Position) | Filing History |
| 2021-06-25 06:08 am Purchase | 2021-06-15 | 13G | Janux Therapeutics, Inc. JANX | Bregua Corp | 3,749,250 9.000% | 3,749,250 (New Position) | Filing History |
| 2021-06-25 06:07 am Purchase | 2021-06-15 | 13D | Janux Therapeutics, Inc. JANX | Avalon Ventures XI L.P. | 8,896,709 21.400% | 8,896,709 (New Position) | Filing History |
| 2021-06-21 8:17 pm Purchase | 2021-06-15 | 13D | Edgewise Therapeutics, Inc. EWTX | ORBIMED ADVISORS LLC | 3,042,764 7.300% | 3,042,764 (New Position) | Filing History |
| 2021-06-16 5:20 pm Purchase | 2021-06-15 | 13D | Janux Therapeutics, Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 8,670,644 20.800% | 8,670,644 (New Position) | Filing History |